Iron Bisglycinate vs Ferrous Sulfate: Which Iron Supplement Is Better?

How Iron Absorption Works

Most dietary iron is in the ferric (Fe3+) state, which must be reduced to the ferrous (Fe2+) state by duodenal brush border enzymes before it can be absorbed via the divalent metal transporter 1 (DMT-1) in the proximal small intestine. This reduction step is enhanced by an acidic gastric environment and by reducing agents such as vitamin C.

Heme iron (from animal products) uses a separate, more efficient transporter and is absorbed at approximately two to three times the rate of non-heme iron. Ferrous sulfate and iron bisglycinate are both non-heme iron forms but use partially different absorption mechanisms, which accounts for their differing tolerability and efficacy profiles.

Ferrous Sulfate: the Standard Option

How it works

Ferrous sulfate provides iron in the Fe2+ form, which is directly ready for absorption via DMT-1. It is highly soluble in gastric acid, releasing iron rapidly in the stomach and proximal duodenum. This rapid release is effective for absorption but also means that a significant proportion of the dose encounters the gastric mucosa as free ionic iron, which is reactive and irritating. Gastrointestinal side effects occur in 25 to 75 percent of users depending on dose, individual sensitivity, and preparation form (plain tablets vs. modified-release).

Efficacy

Ferrous sulfate has a long evidence base and is the reference standard against which other iron forms are compared. It effectively raises serum ferritin and hemoglobin when taken at therapeutic doses in confirmed iron-deficient individuals. Standard therapeutic doses typically range from 60 to 200 mg of elemental iron per day, though lower doses (40 to 80 mg elemental) taken every other day have been shown in recent research to achieve comparable ferritin repletion with better tolerability. Dose specifics should be determined by a provider based on the severity of deficiency.

Limitations

The principal limitation is tolerability. Constipation, nausea, and epigastric pain are common and are the leading causes of non-adherence. Ferrous sulfate also significantly inhibits the absorption of several medications (thyroid hormone, fluoroquinolone antibiotics, tetracyclines) and should be taken two hours apart from these when co-prescribed. Iron absorption is inhibited by calcium, polyphenols, and phytates, which are common in the dietary patterns of individuals who most need iron repletion (vegetarians, frequent cereal consumers).

Iron Bisglycinate: the Chelated Alternative

How it works

Iron bisglycinate is a chelated form of iron in which ferrous iron is bound to two glycine molecules. This chelation protects the iron from forming poorly absorbed complexes with dietary inhibitors (phytates, polyphenols, calcium) in the gut lumen, allowing it to be absorbed as an intact chelate via peptide transporters in addition to the standard DMT-1 pathway. The iron is released from glycine in the mucosal cell rather than the intestinal lumen, reducing the exposure of the gastric mucosa to free ionic iron and explaining the improved tolerability profile.

Efficacy

Multiple clinical comparisons show that iron bisglycinate achieves comparable or superior increases in ferritin and hemoglobin relative to ferrous sulfate, often at a lower elemental iron dose. A key advantage is that chelated iron is less affected by dietary inhibitors, making it a particularly useful form for vegetarians, individuals who cannot separate iron supplementation from meals, or those who have limited gastric acid production (older adults, proton pump inhibitor users).

Tolerability

Head-to-head comparisons consistently show significantly lower rates of constipation, nausea, and epigastric discomfort with iron bisglycinate compared to ferrous sulfate at equivalent elemental iron doses. This translates into substantially better adherence in clinical settings, which is clinically meaningful: a supplement that is tolerated and taken consistently is more effective than a theoretically superior supplement that is discontinued due to side effects.

Limitations

The primary limitation of iron bisglycinate is cost. Chelated iron supplements are typically three to five times more expensive than ferrous sulfate for equivalent elemental iron content. For individuals who tolerate ferrous sulfate well, the additional cost provides limited additional benefit.

Comparison Summary

• Absorption pathway — Ferrous sulfate uses DMT-1 (ionic iron), while iron bisglycinate uses DMT-1 plus peptide transporters (chelate)
• Dietary inhibitor sensitivity — Ferrous sulfate is highly sensitive (phytates, polyphenols, and calcium reduce absorption), while iron bisglycinate has low sensitivity because chelation protects against inhibitors
• GI tolerability — Ferrous sulfate has moderate to poor tolerability with a 25–75% side effect rate, while iron bisglycinate has good tolerability with significantly lower GI side effects
• Efficacy for ferritin repletion — Ferrous sulfate is well-established as the reference standard, while iron bisglycinate is comparable or superior in most comparisons
• Cost — Ferrous sulfate is low-cost with generics widely available, while iron bisglycinate is typically 3–5x more expensive
• Best suited for — Ferrous sulfate works well for those who tolerate iron supplements and are cost-sensitive, while iron bisglycinate is better for those with GI sensitivity, vegetarians, PPI users, and the elderly

Which Biomarkers Should You Test before and during Iron Supplementation?

Iron supplementation should be guided by laboratory confirmation of deficiency and monitored to assess response and avoid excess. The key markers:

• Ferritin — Iron storage; most sensitive marker for depletion; primary target for repletion monitoring
• Hemoglobin — Oxygen-carrying capacity; falls later than ferritin in iron deficiency
• MCV (Mean Corpuscular Volume) — Red cell size; microcytic pattern in iron deficiency anemia
• Iron saturation + TIBC — Transport capacity; low saturation with high TIBC is classic iron deficiency pattern

Superpower's Baseline Blood Panel includes ferritin, hemoglobin, MCV, serum iron, iron saturation, and TIBC in a single draw, providing the complete picture needed to confirm iron deficiency, characterize its severity, and monitor response to supplementation. Testing before starting supplementation and again after 8 to 12 weeks provides the data needed to assess whether the chosen form and dose are effective.